Stay updated on DESTINY-B12 Clinical Trial
Sign up to get notified when there's something new on the DESTINY-B12 Clinical Trial page.

Latest updates to the DESTINY-B12 Clinical Trial page
- Check5 days agoChange DetectedPage metadata updated to v3.0.2 with September 2025 dates; May 2025 metadata removed and new dates added, with removal of the 'Back to Top' link.SummaryDifference0.4%
- Check13 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as recent publications related to trastuzumab deruxtecan and brain tumors. Notably, the previous version's references to trastuzumab and certain MedlinePlus topics have been removed.SummaryDifference4%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to DESTINY-B12 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DESTINY-B12 Clinical Trial page.